Quentin Hill: Collaborative Progress in Immune Thrombocytopenia Drug Development
Quentin Hill, Consultant Haematologist at Leeds Teaching Hospitals NHS Trust, shared Caroline Voltz-Girolt‘s post on LinkedIn, adding:
“In 2014, the EMA published guidelines for the development of medicinal products intended for treatment of chronic ITP.
The workshop below is part of a workstream that will result in an update of those guidelines. Very grateful to the EMA for taking the perspectives of clinicians and expert patients into consideration, and looking forward to publication of this important update.
Thanks also to Caroline Voltz-Girolt for seamless organisation”
Caroline Voltz-Girolt, Senior Scientific Officer in Office of Advanced Therapies and Haemato-Oncology at European Medicines Agency, shared a post on LinkedIn:
“On 30 June 2026, EMA organised a workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia.
We had highly insightful discussions on this topic. A sincere thank you to all the speakers for their comprehensive presentations, thoughtful perspectives, and excellent contributions to the discussion.”
Stay updated with Hemostasis Today.
-
Jul 31, 2026, 10:29Thomas Gowa: WFH Cornerstone Initiative Strengthens Clinical Capacity in Hemophilia Care
-
Jul 31, 2026, 10:08Bushra Salman: Avatrombopag Shows Promise in Heavily Pretreated Chronic ITP
-
Jul 31, 2026, 09:58Alejandro Godoy: Optimizing Perioperative Management of Direct Oral Anticoagulants
-
Jul 31, 2026, 09:36Konstanze Aurich: Emerging Blood-Derived Products in Transfusion Medicine
-
Jul 31, 2026, 09:21Caitlin Raymond: Does Drinking More Calcium and Magnesium Every Day Raise the Calcium in My Blood?
-
Jul 31, 2026, 07:54Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
-
Jul 31, 2026, 07:31Krishna Athmakuri: Evaluating Left Atrial Appendage Occlusion Against Oral Anticoagulation
-
Jul 31, 2026, 04:35Lukas Bastian Otto: Bow Hunter’s Syndrome as a Hidden Cause of Cerebellar Infarction
-
Jul 31, 2026, 04:05Shadi Tabibian: Understanding Thrombotic Risk in Rare Bleeding Disorders